Ashan Mudiyanselage Ashan Indika Gunarathne

Prof. Ashan Mudiyanselage Ashan Indika Gunarathne

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Open access
PDF file
TBTimothy Betts
Timothy Betts
PCPatrick A Calvert
Patrick A Calvert
LGLee N Graham
Lee N Graham
GCGerald J Clesham
Gerald J Clesham
AGAshan Mudiyanselage Ashan Indika Gunarathne
Ashan Mudiyanselage Ashan Indika Gunarathne
DHDavid Hildick-Smith
David Hildick-Smith
Percutaneous left atrial appendage occlusion aims to reduce the risk of stroke in patients with AF, particularly those who are not good candidates for systemic anticoagulation. The procedure has been studied in large international randomised trials and registries and was approved by the National Institute for Health and Care Excellence in 2014 and by NHS England in 2018. This position statement summarises the evidence for left atrial appendage occlusion and presents the current indications. The options and consensus on best practice for pre-procedure planning, undertaking a safe and effective implant and appropriate post-procedure management and follow-up are described. Standards regarding procedure volume for implant centres and physicians, the role of multidisciplinary teams and audits are highlighted.

14 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Tarek AbdeldayemTarek Abdeldayem
Tarek Abdeldayem
AGAshan Mudiyanselage Ashan Indika Gunarathne
Ashan Mudiyanselage Ashan Indika Gunarathne
MFMohamed Farag
Mohamed Farag
Mohammad AlkhalilMohammad Alkhalil
Mohammad Alkhalil
MEMohaned Egred
Mohaned Egred
Circulatory disturbances in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) present significant challenges in interventional cardiology. This review examines the pathophysiological mechanisms, management strategies, and outcomes associated with these hemodynamic complications, ranging from transient hypotension to severe cardiogenic shock (CS). The complex interplay between myocardial ischemia, reperfusion injury, and procedural stress creates a dynamic circulatory environment that requires careful monitoring and intervention. The review analyzes various causes of circulatory disturbances, including vasovagal reflexes, allergic reactions, cardiac arrhythmias, acute ischemia, and procedural complications. It emphasizes the importance of early recognition and appropriate management of these conditions to improve patient outcomes. The progression from hypotension to CS is examined, with a focus on assessment tools, prognostication, and revascularization strategies. The role of mechanical circulatory support devices in managing severe circulatory compromise is discussed, including intra-aortic balloon pumps, Impella devices, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Recent randomized controlled trials have yielded mixed results regarding the efficacy of these devices, highlighting the need for a nuanced, patient-centered approach to their use. This comprehensive analysis provides clinicians with a framework for anticipating, identifying, and managing circulatory disturbances in ACS patients undergoing PCI. It underscores the importance of risk stratification, multidisciplinary approaches, and ongoing research to optimize patient care and improve outcomes in this high-risk population.

1 January 2024 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
Tarek AbdeldayemTarek Abdeldayem
Tarek Abdeldayem
AGAshan Mudiyanselage Ashan Indika Gunarathne
Ashan Mudiyanselage Ashan Indika Gunarathne
Background. Primary percutaneous coronary intervention (PPCI) is the treatment of choice for patients with ST‐elevation myocardial infarction (STEMI). Delayed reperfusion leads to increased morbidity and mortality. Secular trends in the impact of interhospital transfers (IT) on long‐term mortality in the United Kingdom (UK) have not been previously investigated. We analyzed the impact of IT on 5‐year mortality in STEMI patients admitted to a tertiary care center in the UK (East Midlands North). Methods. Data of STEMI patients admitted to Nottingham University Hospitals NHS Trust from 2011 to 2016 were acquired from the National Institute for Cardiovascular Outcomes Research dataset (NICOR) and then combined with local patient‐level data and mortality data from National Statistics. The baseline characteristics and mortality data of the interhospital transfer (IT) group were compared to those of a gender and age‐matched direct admission (DA) group. Results. Of the total cohort (N = 2386), 29.9% of patients were admitted to the PPCI center via the interhospital transfer (IT) route. Cardiovascular risk profiles in both DA and IT groups were comparable. Five‐year Kaplan–Meier (KM) survival analysis revealed better survival in the direct admission group (83% vs. 77.3%; p ≤ 0.001). In multivariate analysis, increased mortality was associated with severe left ventricular impairment (HR 4.7, 95% CI 2.9–7.6), the presence of cardiogenic shock (HR 3.6 (2.7–4.8)), chronic kidney disease (HR 2.56 (1.4–4.5)), smoking (HR 1.45 (1.1–1.8)), male gender (HR 1.7 (1.4–2.01)), and diabetes (HR 1.4 (1.07–1.8)). The radial access and call‐to‐balloon time less than 120 minutes were also associated with lower mortality (HR 0.52 (0.43–0.63): HR 0.75 (0.61–0.92)). Conclusion. Despite advancements in communication, technology, patient education, transportation systems, and guidelines within the UK’s NHS over the last decade, the delays incurred by IT for STEMI patients remain substantial and are associated with a poor prognosis.

5 March 2024 in Interventional Cardiology: Reviews, Research, Resources
Verified
Journal Article
Open access
PDF file
TBTimothy Betts
Timothy Betts
PCPatrick A Calvert
Patrick A Calvert
LGLee N Graham
Lee N Graham
GCGerald J Clesham
Gerald J Clesham
AGAshan Mudiyanselage Ashan Indika Gunarathne
Ashan Mudiyanselage Ashan Indika Gunarathne
DHDavid Hildick-Smith
David Hildick-Smith
Percutaneous left atrial appendage occlusion aims to reduce the risk of stroke in patients with AF, particularly those who are not good candidates for systemic anticoagulation. The procedure has been studied in large international randomised trials and registries and was approved by the National Institute for Health and Care Excellence in 2014 and by NHS England in 2018. This position statement summarises the evidence for left atrial appendage occlusion and presents the current indications. The options and consensus on best practice for pre-procedure planning, undertaking a safe and effective implant and appropriate post-procedure management and follow-up are described. Standards regarding procedure volume for implant centres and physicians, the role of multidisciplinary teams and audits are highlighted.

18 November 2021 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
AGAshan Mudiyanselage Ashan Indika Gunarathne
Ashan Mudiyanselage Ashan Indika Gunarathne
JTJoon Tan
Joon Tan
RVRichard Varcoe
Richard Varcoe
SBSanjay Bhandari
Sanjay Bhandari
AFAmir Faour
Amir Faour
KBKamran Baig
Kamran Baig

8 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Tarek AbdeldayemTarek Abdeldayem
Tarek Abdeldayem
AGAshan Mudiyanselage Ashan Indika Gunarathne
Ashan Mudiyanselage Ashan Indika Gunarathne
MFMohamed Farag
Mohamed Farag
Mohammad AlkhalilMohammad Alkhalil
Mohammad Alkhalil
MEMohaned Egred
Mohaned Egred
Circulatory disturbances in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) present significant challenges in interventional cardiology. This review examines the pathophysiological mechanisms, management strategies, and outcomes associated with these hemodynamic complications, ranging from transient hypotension to severe cardiogenic shock (CS). The complex interplay between myocardial ischemia, reperfusion injury, and procedural stress creates a dynamic circulatory environment that requires careful monitoring and intervention. The review analyzes various causes of circulatory disturbances, including vasovagal reflexes, allergic reactions, cardiac arrhythmias, acute ischemia, and procedural complications. It emphasizes the importance of early recognition and appropriate management of these conditions to improve patient outcomes. The progression from hypotension to CS is examined, with a focus on assessment tools, prognostication, and revascularization strategies. The role of mechanical circulatory support devices in managing severe circulatory compromise is discussed, including intra-aortic balloon pumps, Impella devices, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Recent randomized controlled trials have yielded mixed results regarding the efficacy of these devices, highlighting the need for a nuanced, patient-centered approach to their use. This comprehensive analysis provides clinicians with a framework for anticipating, identifying, and managing circulatory disturbances in ACS patients undergoing PCI. It underscores the importance of risk stratification, multidisciplinary approaches, and ongoing research to optimize patient care and improve outcomes in this high-risk population.